“Plug-and-Play” CAR T Platform Enables Post-Infusion Retargeting

Meditope-enabled CAR T cells can be tracked, selectively expanded, and directed toward additional tumor antigens using externally administered protein adaptors

• September 23, 2026

• 3 min

• The Medicine Maker